VREX
Varex Imaging Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -5.6% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 16.05K | $296,388 | n/a | −2 |
| Q2 2026 | 73 | +1 | 23.53M | $245.80M | +4 | −3 |
| Q1 2026 | 74 | -2 | 23.68M | $251.27M | +5 | −7 |
| Q4 2025 | 76 | +1 | 25.15M | $293.07M | +1 | n/a |
| Q3 2025 | 16 | 0 | 13.89M | $172.28M | +1 | −1 |
| Q2 2025 | 13 | -1 | 12.33M | $106.93M | +1 | −2 |
| Q1 2025 | 11 | -1 | 6.63M | $76.87M | n/a | −1 |
| Q4 2024 | 12 | 0 | 6.74M | $98.34M | +1 | −1 |
| Q3 2024 | 11 | +1 | 5.38M | $64.17M | +3 | −2 |
| Q2 2024 | 10 | n/a | 2.74M | $40.40M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.76M | n/a | $25.68M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.46M | -12.1% | $21.29M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (passive) | 930.65K | +0.2% | $13.58M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 688.00K | -32.0% | $10.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 570.88K | +18.0% | $8.33M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 6 | D. E. Shaw & Co. ✦ | 381.59K | +0.2% | $5.57M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Arrowstreet Capital ✦ | 288.63K | +2223.3% | $4.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 259.70K | +9.6% | $3.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 226.70K | -44.9% | $3.31M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 143.42K | -31.4% | $2.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 15.41K | +22.3% | $225,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 15.36K | New | $224,059 | 0.0% | New | 1 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $224,059 | 0.0% |
Exited
| Point72 Asset Management | $414,816 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 176 holders, 41.13M shares, $401.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 8.12K sh · $150,076
Officer · 130.00K sh · $2.40M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology